These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10323590)

  • 1. Improvement of exercise capacity of rats with chronic heart failure by long-term treatment with trandolapril.
    Yamaguchi F; Kawana K; Tanonaka K; Kamano I; Igarashi T; Gen E; Fujimoto Y; Maki T; Sanbe A; Nasa Y; Takeo S
    Br J Pharmacol; 1999 Apr; 126(7):1585-92. PubMed ID: 10323590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.
    Toyoshima H; Nasa Y; Kohsaka Y; Isayama Y; Yamaguchi F; Sanbe A; Takeo S
    Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
    Yamaguchi F; Sanbe A; Takeo S
    Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarction.
    Tanonaka K; Toga W; Yoshida H; Furuhama K; Takeo S
    Br J Pharmacol; 2001 Nov; 134(5):969-76. PubMed ID: 11682444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heart.
    Takahashi M; Tanonaka K; Yoshida H; Oikawa R; Koshimizu M; Daicho T; Toyo-Oka T; Takeo S
    Cardiovasc Res; 2005 Feb; 65(2):356-65. PubMed ID: 15639474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of trandolapril on cardiac angiotensin I converting enzyme activity in rats with chronic heart failure following myocardial infarction.
    Sanbe A; Tsukada J; Takeo S
    Jpn Heart J; 1995 Jul; 36(4):451-63. PubMed ID: 7474361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.
    Varin R; Mulder P; Tamion F; Richard V; Henry JP; Lallemand F; Lerebours G; Thuillez C
    Circulation; 2000 Jul; 102(3):351-6. PubMed ID: 10899101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress.
    Varin R; Mulder P; Richard V; Tamion F; Devaux C; Henry JP; Lallemand F; Lerebours G; Thuillez C
    Circulation; 1999 Jun; 99(22):2951-7. PubMed ID: 10359741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with trandolapril on augmented vasoconstriction in rats with chronic heart failure.
    Okumura Y; Nasa Y; Sanbe A; Toga W; Takeo S
    J Card Fail; 1996 Dec; 2(4):301-10. PubMed ID: 8989645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
    Sanbe A; Tanonaka K; Kobayasi R; Takeo S
    J Mol Cell Cardiol; 1995 Oct; 27(10):2209-22. PubMed ID: 8576937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril.
    Toga W; Tanonaka K; Takeo S
    Biol Pharm Bull; 2007 Jan; 30(1):105-10. PubMed ID: 17202668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.
    Wang LC; Ma H; He JG; Liao XX; Chen WF; Leng XY; Ma L; Mai WY; Tao J; Zeng WT; Liu J; Dong YG; Tang AL; Feng C
    Chin Med J (Engl); 2005 May; 118(9):731-7. PubMed ID: 15899134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
    Yoshida H; Takahashi M; Tanonaka K; Maki T; Nasa Y; Takeo S
    Br J Pharmacol; 2001 Sep; 134(1):150-60. PubMed ID: 11522607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
    Sanbe A; Takeo S
    Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
    Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
    Sanbe A; Tanonaka K; Niwano Y; Takeo S
    J Pharmacol Exp Ther; 1994 Apr; 269(1):51-6. PubMed ID: 8169851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular exercise improves cardiac contractile activation by modulating MHC isoforms and SERCA activity in orchidectomized rats.
    Vutthasathien P; Wattanapermpool J
    J Appl Physiol (1985); 2015 Oct; 119(7):831-9. PubMed ID: 26272317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in myosin heavy chain isoform gene expression during the transition from compensatory hypertrophy to congestive heart failure in rats.
    Huang Y; Liu H; Li Y
    Chin Med J (Engl); 2001 Feb; 114(2):183-5. PubMed ID: 11780203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
    Schäfer A; Fraccarollo D; Tas P; Schmidt I; Ertl G; Bauersachs J
    Eur J Heart Fail; 2004 Mar; 6(2):151-9. PubMed ID: 14984722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity, skeletal muscle beta-adrenoceptor changes and oxidative metabolism in experimental chronic heart failure.
    Michel C; Chati Z; Mertes PM; Escanye JM; Zannad F
    Fundam Clin Pharmacol; 1998; 12(3):263-9. PubMed ID: 9646058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.